Bimatoprost - Glaucoma / ocular hypertension
You are here : Home > Formulary Search > Bimatoprost - Glaucoma / ocular hypertension
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Blue
Formulations :
- Eye drops
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Note added January 2025 - this drug should be prescribed on recommendation from a specialist.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Bimatoprost
Indication :
Glaucoma / ocular hypertension
Group Name :
Keywords :
Intra-ocular pressure
Brand Names Include :
Lumigan, Zimed, Eyreida, Bimi, VisuPLAIN
Important Information :
Prescribe generically.
Initiation by specialist team before transfer of prescribing to primary care
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Other Indications
Below are listed other indications that Bimatoprost is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Glaucoma / ocular hypertension.
- Acetazolamide
- Apraclonidine
- Betaxolol
- Bimatoprost with timolol
- Brimonidine tartrate
- Brimonidine with timolol
- Brinzolamide
- Brinzolamide with brimonidine
- Brinzolamide with timolol
- Dorzolamide
- Dorzolamide with timolol
- Latanoprost
- Latanoprost with netarsudil
- Latanoprost with timolol
- Levobunolol hydrochloride
- Pilocarpine hydrochloride
- Tafluprost
- Timolol
- Travoprost
- Travoprost with timolol
Committee Recommendations (1)
Primary care prescribers do not have the necessary equipment or skills to perform ocular pressure readings to make a diagnosis. The APC recomments that this product, when used for treatment of glaucoma, should be considered as BLUE.
Note added January 2025 - this drug should be prescribed on recommendation from a specialist.